Relative Risk (95% CI) of receiving a blood transfusion according to G6PD status following treatment with chlorproguanil-dapsone+artesunate (CD+A) or amodiaquine+sulphadoxine-pyrimethamine (AQ+SP).

cOne patient G6PD (B) was transfused at day 14 for a concomitant disease. Results excluding this case are: RR 49.8 (5.5, 455.5), RR 42.7 (4.6, 393.1) and RR 20.4 (2.2, 191.7), for hemizygous boys, hemizygous boys+homozygous girls, and hemizygous boys+homozygous girls+heterozygous girls, respectively.